https://techcrunch.com/2020/05/27/eli-lillys-covid-19-therapy-development-partner-abcellera-raises-105-million/

When AbCellera won a $30 million contract with the Defense Advanced Research Projects Agency to develop therapeutic countermeasures against viral outbreaks two years ago, it’s safe to assume that no one thought the technology would be so vitally important so soon.

The work AbCellera was doing was part of a high-priority initiative from DARPA’s Biological Technology Office called the Pandemic Prevention Platform which was designed to finance the development of technologies for pandemic response capable of developing countermeasures within sixty days of the isolation of a viral pathogen.